ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Donors, marginal"

  • 2019 American Transplant Congress

    Utilization of Donor Kidneys with Acute Kidney Injury in Pediatric Transplantation

    C. S. Hwang1, B. Tanriover2, S. Levea2, D. Desai1, V. Ariyamuthu2, P. Vagefi1, M. MacConmara1

    1Surgery, UT Southwestern, Dallas, TX, 2Medicine, UT Southwestern, Dallas, TX

    *Purpose: Donor kidneys that are otherwise healthy with acute kidney injury (AKI) are increasingly used in adult transplant programs. We sought to examine the experience…
  • 2019 American Transplant Congress

    The Model For Predicting eGFR At A Year After Donation In Living Related Kidney Transplant Donors

    K. Shinoda, K. Sakurabayashi, T. Mizutani, Y. Takahashi, Y. Hyodo, Y. Itabashi, M. Muramatsu, T. Kawamura, S. Shishido, K. Sakai

    Nephrology, Toho University Faculty of Medicine, Tokyo, Japan

    *Purpose: Predicting post-donation kidney function precisely is considerably beneficial for both candidates of living-related kidney donors and their physicians when judging the feasibility of kidney…
  • 2019 American Transplant Congress

    Sequestration of PLIN2 Regulates High-Fat Diet Induced Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in a Mouse Model of Ischemia Reperfusion Injury

    K. Loh1, X. Liu1, L. Belyayev1, C. Albanese2, W. Cui1, T. M. Fishbein1, K. M. Khan1, A. Kroemer1

    1Transplant, MedStar Georgetown Transplant Institute, Washington, DC, 2Oncology, Georgetown University, Washington, DC

    *Purpose: This study aimed to define characteristics and mechanisms leading to nonalcoholic fatty liver disease and metabolic syndrome in a fatty liver mouse model that…
  • 2019 American Transplant Congress

    Predicting Deceased Donor Kidney Transplant Outcomes: Comparing KDRI/KDPI with Machine Learning

    E. Pahl

    HealthTech Solutions, Inc., Coralville, IA

    *Purpose: To better predict outcomes of graft survival in kidney donation and ultimately save more lives for those waiting on the list.*Methods: Machine learning methods…
  • 2019 American Transplant Congress

    The Impact of Changes in OPTN Oversight of Kidney Programs on Organ Yield and Offer Acceptance Practices

    A. Wey1, N. Salkowski1, B. Carrico2, S. Sheppard2, B. Kasiske1, B. Thompson1, A. Israni1, J. Snyder1

    1SRTR, Minneapolis, MN, 2OPTN, Richmond, VA

    *Purpose: In March 2017, the Membership and Professional Standards Committee (MPSC) of the Organ Procurement and Transplantation Network implemented an operational rule to increase the…
  • 2019 American Transplant Congress

    Utilization of DCD Donors >50 Years Old for Liver Transplantation

    T. Chaly, K. Hoidal, C. Cashman, J. Brink, A. Mehrotra, W. Van der Werf

    Arizona Transplant Associates, PC, Phoenix, AZ

    *Purpose: End stage liver disease is becoming more prevalent in the United States with approximately 4.9 million adults carrying the diagnosis. It is estimated that…
  • 2019 American Transplant Congress

    Donation after Cardiac Simultaneous Liver-Kidney: An Updated Perspective

    R. Nunez, P. Morgan, A. Mathur, K. S. Reddy, A. Moss, B. Aqel, C. Jadlowiec

    Mayo Clinic AZ, Phoenix, AZ

    *Purpose: Historically, the outcomes from donation after cardiac death (DCD) donors have been shown to be inferior as compared to those of donation after brain…
  • 2019 American Transplant Congress

    Viability Testing and Transplantation of Marginal Donor Livers (VITTAL) Trial Outcomes: Proteomic Analysis of Perfusates from Livers Undergoing Normothermic Machine Liver Perfusion Reveals Biomarkers Predictive of Graft Viability and Post-Transplant Complications

    S. Afford1, L. Wallace1, J. Attard1, Y. Boteon1, R. Laing1, J. Yu2, T. Perera3, D. Mirza4, H. Mergental5

    1Centre for Liver and Gastroenterology Research, University of Birmingham, Birmingham, United Kingdom, 2The School of Biosciences Proteomics Facility, University of Birmingham, Birmingham, United Kingdom, 3Liver Unit, Queen Elizabeth University Hospital, Birmingham, United Kingdom, 4Liver Unit, The Queen Elizabeth University Hospital, Birmingham, United Kingdom, 5The Liver Unit, Queen Elizabeth University Hospital, Birmingham, United Kingdom

    *Purpose: The VITTAL clinical trial demonstrated that post-ischaemic normothermic machine perfusion(NMP) can increase utilisation of livers from the marginal pool of extended criteria donors (ECD).…
  • 2019 American Transplant Congress

    A New Risk Stratification Scoring System for Deceased Donor Kidneys and Suitable Candidates for Marginal Kidneys in Korea

    T. Koo1, J. Ryu1, S. Park2, S. Lee2, J. Hwang2, C. Ahn3, J. Yang1

    1Transplantation Center, Seoul National University Hospital, Seoul, Korea, Republic of, 2Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea, Republic of, 3Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of

    *Purpose: The dichotomous criteria for expanded criteria donor (ECD) vs. standard criteria donor (SCD) have been useful for making decisions about accepting deceased donor kidney…
  • 2019 American Transplant Congress

    Hepatitis C Antibody Positive (HCV Ab+)/Nucleic Acid Test Negative (NAT -) Deceased Donor Kidney Transplantation into Hepatitis C Negative (HCV -) Recipients: Is It Safe?

    Y. Taehwan, A. Rajab, G. Bumgardner, t. Pesavento, R. Daloul, A. Michaels, K. Washburn, A. El-Hinnawi

    Ohio State University, Columbus, OH

    *Purpose: Kidneys procured from HCV Ab+/NAT - are not routinely used due to concern for HCV transmission into recipients. However, there has been no report…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 29
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences